← Leaderboards
Mark A Hull
Massachusetts General Hospital
$1,180,060
Attributed
$3,185,111
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $710.1K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,185,111 · 1
By mechanism
R01$3,185,111 · 1
Top collaborators
- Wendy S. Garrett6 shared
- Andrew T Chan5 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mingyang Song$6,525,328
- Andrew T Chan$39,910,857
- Paula I Watnick$19,648,431
- Christopher Irwin Moore$9,205,090
- Ralph Weissleder$110,468,710
Others in their field
Other Emerging Leaders on “Aftercare”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,888,963
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
- Ki Young Chung · Prisma Health - Upstate$8,495,983
- Deanna A Kulpa · Emory University$8,444,989
Research focus
AftercareAdenomaAnti-Tumor Immune ResponseBacteriaAnti-Inflammatory AgentsBeneficial MicroorganismBifidobacteriumBiobankBiological MarkersBloodBlood SpecimenCancer EtiologyCancer ImmunotherapyCancer SurvivalCessation Of LifeChemokineChronicCohortColon Cancer PatientsColorectal AdenomaColorectal CancerColorectal Cancer ProgressionColorectal Cancer TreatmentColorectal Surgery
Grant awards (6)
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer livermetastasis$710,138
R01 · FY2024 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer$1
R01 · FY2024 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer$599,135
R01 · FY2023 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer$605,801
R01 · FY2022 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer$626,197
R01 · FY2021 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer$643,839
R01 · FY2020 · CA